USG PECS vs LIA for Breast Cancer Surgery

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

November 25, 2018

Study Completion Date

November 25, 2018

Conditions
Breast Cancer Female
Interventions
PROCEDURE

USG PECS2 with Drug A (active)

Ultrasound guided Pecs 2 blocks with 0.25% levobupivacaine

PROCEDURE

USG PECS2 with Drug P (placebo)

Ultrasound guided Pecs 2 blocks with placebo (0.9% saline)

PROCEDURE

Wound infiltration with Drug P (placebo)

Wound infiltration at the end of surgery with Drug P (0.9% saline)

PROCEDURE

Wound infiltration with Drug A (active)

Wound infiltration at the end of surgery with 0.25% levobupivacaine

Trial Locations (1)

BT63 5QQ

Craigavon Area Hospital, Portadown

All Listed Sponsors
collaborator

Southern Health and Social Care Trust

OTHER_GOV

lead

National Health Service, United Kingdom

OTHER_GOV

NCT03555227 - USG PECS vs LIA for Breast Cancer Surgery | Biotech Hunter | Biotech Hunter